The Comparative Analysis of the Effects on Plaque Volume and Tissue Characteristics Between Combined Therapy With STAatin Plus FENOfibrate and Statin Alone in Mild to Moderate, Non- Intervened Coronary Artery Stenosis (STAFENO Trial)

Trial Profile

The Comparative Analysis of the Effects on Plaque Volume and Tissue Characteristics Between Combined Therapy With STAatin Plus FENOfibrate and Statin Alone in Mild to Moderate, Non- Intervened Coronary Artery Stenosis (STAFENO Trial)

Recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Aug 2016

At a glance

  • Drugs Fenofibrate (Primary) ; Rosuvastatin
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Acronyms STAFENO
  • Most Recent Events

    • 22 Aug 2016 Planned number of patients changed from 200 to 160.
    • 22 Aug 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
    • 22 Aug 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top